LFG
IMNM icon

Larson Financial Group’s Immunome IMNM Stock Holding History

Larson Financial Group’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.86K Buy
85
+2
+2% +$45 ﹤0.01% 2978
2025
Q4 		$1.78K Sell
83
-7
-8% -$123 ﹤0.01% 2805
2025
Q3 		$1.05K Buy
90
+23
+34% +$229 ﹤0.01% 2905
2025
Q2 		$623 Buy
+67
New +$549 ﹤0.01% 2798

Other funds holding IMNM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return

Larson Financial Group's IMNM Position: Q1 2026 in Review

Larson Financial Group increased its Immunome (IMNM) stake by 2.4% in Q1 2026, buying an estimated $45 and bringing the position to 85 shares worth $1.86K. The position accounts for ﹤0.01% of the portfolio, ranked #2978.

Larson Financial Group first reported a position in IMNM in Q2 2025 and has held it in 4 quarters since. 200 funds tracked by Wall St. Rank hold IMNM as of Q1 2026.

  • Larson Financial Group held 85 shares of Immunome worth $1.86K as of Q1 2026.
  • Larson Financial Group bought 2 Immunome shares in Q1 2026, an estimated $45.
  • Immunome made up ﹤0.01% of Larson Financial Group's portfolio in Q1 2026, its #2978 holding.
  • Larson Financial Group first reported a position in Immunome in Q2 2025 and has held it in 4 quarters since.
  • 200 funds tracked by Wall St. Rank held Immunome as of Q1 2026.

Based on Larson Financial Group's 13F filing for Q1 2026, filed 15 May 2026.